Related Experiment Videos
Skull base chondrosarcoma originating from the petroclival junction
John S Oghalai1, James L Buxbaum, Robert K Jackler
1Department of Otolaryngology, Head and Neck Surgery, University of California, San Francisco, California, USA. jso@bcm.tmc.edu
Summary
Skull base chondrosarcoma often affects the petroclival junction. Postoperative radiotherapy significantly reduces tumor recurrence risk, improving patient survival rates.
Area of Science:
- Neuro-oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Skull base chondrosarcoma is a rare bone tumor.
- Understanding its presentation and treatment is crucial for patient outcomes.
Purpose of the Study:
- To define the clinical presentation of skull base chondrosarcoma.
- To elucidate optimal surgical strategies.
- To identify the role of postoperative radiotherapy.
Main Methods:
- Retrospective review of 33 patients with skull base chondrosarcoma.
- Analysis of tumor location, symptoms, surgical approaches, and outcomes.
- Follow-up averaged 7.7 years.
Main Results:
- Petroclival junction is the most common location (n=29).
- Diplopia (48%) and headache (45%) were frequent symptoms.
- Postoperative radiotherapy (82%) significantly reduced recurrence risk (OR 28; p=0.007).
- 5-year survival was 85%, 10-year survival was 77%.
Conclusions:
- Skull base chondrosarcoma characteristically erodes the petroclival junction.
- Surgical resection via extradural subtemporal craniotomy is a primary strategy.
- Postoperative radiotherapy is essential for reducing recurrence.